Filtered By Specialty: Service Category: Key Service: Region: Country:

Company Profiles2,311-2,320 of 4,239 Companies

Want to add your company?

GET FULL ACCESS!

USER GUIDE DATABASE // PRICING // FAQ
Any question? Contact us!

PharmaVize

Logo PharmaVize
  • Contract manufacturing, filling and packaging
  • Human Medicines
  • Europe

You have a promising (New) Chemical Entity and you are preparing for Preclinical or Early Phase Clinical Studies? You are looking for contractors who can characterise, formulate, GMP produce, label and release your clinical trial material? Well, here you have found a single, reliable source that can meet your clinical supply material needs. Our business is to develop and manage your Early Clinical Supply Materials from design to delivery. We offer you an integrated and tailored service level. More »

Exquiron

Logo Exquiron
  • Pre-clinical development and testing, pre-clinical CRO
  • Human Medicines
  • Europe

Exquiron is dedicated to contract research in early stage drug discovery. Our services span from assay development and adaptation for hit finding and profiling purposes to compound selection, high throughput screening, selectivity testing and hit characterization, and SAR expansion. Our scientists will work with you to identify the most suitable approach to reach your program milestones as rapidly, efficiently and economically as possible. Our team brings proven expertise to all areas of the hit identification process, including broad target class coverage, assay systems and technologies, assembly of compound screening decks, high throughput screening, data processing, mining and interpretation, quality control, project management, and reporting. Exquiron is now part of the Aptuit group of companies. More »

SCIENTEX

Logo SCIENTEX
  • Consulting - strategy and development
  • Human Medicines
  • Europe, North America, South America, Asia, Australia & New Zealand, Worldwide

Mandated by its clients, Scientex is acting globaly and pragmatically on all aspects of corporate development and corporate finance, and supports them on strategic Intelligence & business communication with specific tools : http://www.scientex.eu/5.html   The objective of SCIENTEX is to allow its clients to enjoy its experience from science to stock exchange, in order to act in the name and on behalf of them, the most effectively possible at corporate level :   http://www.scientex.eu/resources/What+is+the+real+full+cost+of+an+employee.pdf   and to keep on saving time for its clients , being immediately operational. Scientex’s associates are structured to be able to work effectively 60% more than the average working time in Europe : see details in our competitiveness.  Last but not least, working with Scientex will allow you to reduce your labor costs thank to our low cost fees :  http://www.scientex.eu/4.html   Tim Muller founded SCIENTEX : his background : 10 years as a private equity investor & 10 years as a corporate developer, both focused on healthcare industry : Tim started his R&D career as a project engineer on radio-pharmaceuticals at AREVA / CEA in 1993, moved as a pre-clinical pharmaco-chemist for SERVIER laboratories on diabete mellitus & CNS up to pharmaceutical proof of concept & industrial scalability. In 1999, Tim switched to the private equity industry (CDC enterprises & Sofimac Partners) investing in 17 healthcare private companies selected from its 600 life sciences deal flow proactively sourced : 6 companies were acquired by industrials & 4 IPOs, 2 are still private, 5 bankruptcies; generating a double digit IRR . To date, Tim served a "hands on" board member on 23 healthcare companies in Europe. Then, Tim created SCIENTEX in 2006 in order to act as a day to day transition manager in business & corporate development, and M&A (buy & sell side) for small and mid healthcare companies, while he was advising in parallel wealthy individuals on VIX trading & working with private equity funds. Complementary, Tim & Berenice Muller created BIOTECHNEWS, a corporate and financial communication service, targeting up to 500K life sciences investors & industrials including 20% of VP and C-level and board members and 30 000 dealsmakers inside pharma industry.   After +26 corporate development missions in 6 years generating +1Meuros of net profit for Scientex, Tim joined CROSSJECT in 2012 during its restart in order to drive the new business & corporate development.    Then, after the succesful completion of a 472M$ licensing deal; Tim, in its position of member of the executive board, led the $6M refinancing closed in june 2013, managed M&A opportunities & engaged the IPO process, successfully oversubscribed 4,4 x in february 2014 (Photo1 & Photo2). Globally, Tim has been involved in 100 corporate and business transactions to date, including 5 IPOs and 9 M&A   Berenice Muller, now managing director of SCIENTEX, PharmD (2001) & Master degree in Medtech, is developing Scientex offer’s in business development towards European SME in order to cover deeply the 5EU market, while Tim focuses on international operations for all Scientex's clients. Berenice is also updating SCIENTEX's contact database (+30 000 in pharma/biotech deal makers) and SCIENTEX's intelligence database (+21 000 market studies) :  see http://www.scientex.eu/5.html Tim Muller French Landline: +33 240 450 821 (main) French Mobile: +33 645 523 540 tm@scientex.eu (main) Skype id: timotheemuller French Fax: +33 897 502 069 fr.linkedin.com/in/timotheemuller More »

Aptys Pharmaceuticals

  • Formulation development and drug delivery
  • Human Medicines
  • Europe

Since 2002, as a contract research and development organization, we offer to our customers: • Quality control and ICH stability, analytical development and validations • Custom-made formulation and generic development • Production assistance More »

Admescope Ltd.

  • Pre-clinical development and testing, pre-clinical CRO
  • Human Medicines
  • Europe

Admescope is a contract research organization (CRO) providing premium quality ADME-Tox services from tailor-made assays to HTS studies for the pharmaceutical, biotechnology and veterinary industry.  More »

Axis Bioservices

  • Pre-clinical development and testing, pre-clinical CRO
  • Human Medicines
  • Europe

Axis Bioservices is a preclinical contract research organisation with specialist capabilities in oncology, angiogenesis and inflammation.   Our purpose-built facility and highly trained staff means that we can provide many solutions to your out-sourcing requirements. We are a yound but highly experienced company with a flexible, customer-focused attitude. This ensures we collaborate with each client to ensure our services are specifically tailored to their individual needs.   We are committed to accelerating your drug discovery programme by delivering an efficiant, high quality service within a competitive, transparent pricing structure. More »

nlg GmbH (next level globalization)

Logo nlg GmbH (next level globalization)
  • Translation services (medical, clinical, pharmaceutical)
  • Human Medicines
  • Europe, North America

  Without doubt, especially in the healthcare industry nlg has earned the trust of known companies. Our references speak for themselves and we'd be happy to connect you with real-world clients of ours who will speak for us, rather than a sales person. More »

ImmuSmol

  • Analytical laboratory and testing services
  • Human Medicines
  • Europe, Worldwide

ImmuSmol develops small molecule antibodies for research, diagnostic and therapeutic applications. Combining over 25 years of experience in antigen design, we offer to raise antibodies against any molecule under 900 Da. Compatible with existing immunodetection methods (IHC, IF, ELISA, ...), our anti-hapten antibodies represent an attractive alternative to aptamer-based and mass spec technologies for small molecule detection in biological samples :   > Cross specie reactivity, high specificity and binding affinity Specifically selected/validated to meet their application, our monoclonal and polyclonal antibodies can detect small molecules in virtually any biological sample. Unlike proteins, small molecule are indeed conserved throughout phylogenesis.  > Small molecule visualization Combined with immunostaining techniques, our antibodies enable to visualize small molecule distribution in cells and tissues > Small molecule quantification In the context of ELISA/EIA methods, our antibodies constitute a robust and easy-to-implement approach to small molecule quantification in biological fluids, cheaper and faster than LC-MS tools.    Depending on your desired application (research, diagnostics, environmental monitoring, food safety...), we can either raise mouse monoclonals or rabbit polyclonals: > Small molecule monoclonals For industrial applications requiring high reproducibility, availability and scalability > Small molecule polyclonals Fast and low cost development, for mainly for research applications   We also commercialize IHC-validated antibodies for research use and set up a pipeline of monoclonal antibodies against pathometabolites for therapeutic applications. Please visit ImmuSmol website to learn more.  More »

Millmount Healthcare

Logo Millmount Healthcare
  • Contract manufacturing, filling and packaging
  • Human Medicines
  • Europe

We are a wholly Irish-owned organisation providing a outsource packaging service to pharmaceutical, OTC and healthcare manufacturers in Ireland and across the Eurozone. The company was founded in 1999 by Mr. Pascal Keogh. For a decade now, we have delivered unparalleled levels of service to the pharmaceutical and healthcare sector. We are much more than a packaging service provider and can offer our partner's everything from the sourcing of raw packaging materials to the packing and delivery of a whole range of pharmaceutical, veterinary, nutraceutical and healthcare products. We are also equipped to handle all of the necessary inspections, certification and export documentation that our partner's require. More »

Robinson Brothers Ltd

  • Contract manufacturing, filling and packaging
  • Biopharmaceuticals
  • Europe, Worldwide

Robinson Brothers is one of the UK's largest independent manufacturers of speciality organic chemicals, providing a comprehensive package of products and technical services across two distinct global market areas - fine chemicals and polymer chemicals. Our production site in the heart of the Midlands has a full range of facilities, including Research and QC Laboratories, Kilo Lab and Pilot Plant units and over 200,000L of production capacity. We manufacture intermediates for the Pharmaceutical, Agrochemical and Speciality Chemical industries as well as many others and our team of chemists are experts in custom synthesis, contract manufacture and process optimisation. More »

Companies by service category

Companies by regionCompanies by specialty

Outsourcing?

Looking for special service?
Don't spend time on search!

Place Request Anonymously »

Get applications from providers For Free